Sarah Waheed MD
Myeloproliferative Disorder Hematology-Oncology
Hematology-Oncology at Johns Hopkins Kimmel Cancer Center, Sibley Memorial Hospital
Join to view full profile
5255 Loughboro Rd NWWashington, DC 20016
Phone+1 202-660-6125
Dr. Waheed is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Waheed is a hematologist at John Hopkins Kimmel Cancer Center at Sibley Memorial in Washington, DC appointed as Director of Developmental Therapeutics. She received her medical degree from King Edward Medical University and has been in practice 21 years. She specializes in multiple myeloma, waldenstrom's macroglobulinemia, poems syndrome, monoclonal gammopathy of unknown significance, and amylodiosis. She has more than 50 publications and over 500 citings.
Education & Training
University of Tennessee College of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2007
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2001 - 2004
King Edward Medical UniversityClass of 1996
Certifications & Licensure
DC State Medical License 2022 - 2026
AR State Medical License 2007 - 2023
MD State Medical License 2016 - 2023
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 12 citationsAdverse metaphase cytogenetics can be overcome by adding bortezomib and thalidomide to fractionated melphalan transplantsYogesh Jethava, Alan Mitchell, Joshua Epstein, Maurizio Zangari, Shmuel Yaccoby
Clinical Cancer Research. 2017-06-01 - 95 citationsAssessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma.James E. McDonald, Marcus M. Kessler, Michael W. Gardner, Amy Buros, James A. Ntambi
Clinical Cancer Research. 2017-04-15 - Correction: Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study.Archana Hinduja, Kaustubh Limaye, Rahul Ravilla, Appalanaidu Sasapu, Xenofon Papanikolaou
Plos One. 2017-03-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
